Placeholder Banner

BIO’s Brent Erickson in Biofuels Digest Top 10 People in the Advanced Bioeconomy for 2016

February 11, 2016

Washington, D.C. (February 11, 2016) – Biofuels Digest, a top trade publication for the industrial biotech industry, recently published its list of the “Top 100 People in the Advanced Bioeconomy” for 2016. Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization (BIO)’s Industrial and Environmental Section, was number ten.

“I am honored to be recognized by the readers and editorial board of Biofuels Digest. BIO and its members are long-standing leaders and innovators in the biobased economy,” stated Brent Erickson. “BIO is fortunate that many of the top 100 people in the advanced bioeconomy will be speaking or delivering presentations upcoming 2016 World Congress on Industrial Biotechnology.”

Programming for the 2016 BIO World Congress on Industrial Biotechnology, to be held April 17-20 in San Diego, will include presentations from many industry representatives included in the “Top 100 People in the Advanced Bioeconomy” list, including:

Theodora Retsina, CEO, American Process, Inc.;

Alan Shaw, CEO, Calysta;

Sean Sutcliffe, CEO, Green Biologics;

Jason Kelly, CEO, Gingko Bioworks; and

Matt Carr, CEO, Algae Biomass Organization.

The 2016 World Congress on Industrial Biotechnology in San Diego, California, which will be held April 17-20, 2016 at the San Diego Convention Center.

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference, please visit www.bio.org/worldcongress. For assistance, please contact worldcongress@bio.org.

About BIO

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…